Progesterone Receptor Negative Active Not Recruiting Phase 2 Trials for Trastuzumab emtansine (DB05773)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02414646Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast CancerTreatment